Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.80432 | 74 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.58341 | 72 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.65131 | 73 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.50833 | 71 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.56463 | 72 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.19749 | 78 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.72387 | 74 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.66161 | 73 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.79826 | 74 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.55312 | 72 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.6406 | 73 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.65745 | 72 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.8565 | 74 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.67294 | 73 |